Ballentine Partners LLC Has $1.20 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Ballentine Partners LLC lifted its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 15.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,820 shares of the company’s stock after acquiring an additional 2,325 shares during the period. Ballentine […]
More Stories
Pitcairn Co. Acquires New Stake in iShares India 50 ETF (NASDAQ:INDY)
Pitcairn Co. bought a new stake in iShares India 50 ETF (NASDAQ:INDY – Free Report) during the third quarter, according...
Pitcairn Co. Sells 540 Shares of Enpro Inc. (NYSE:NPO)
Pitcairn Co. lessened its position in Enpro Inc. (NYSE:NPO – Free Report) by 12.3% in the third quarter, according to...
Pitcairn Co. Has $601,000 Stake in Omnicom Group Inc. (NYSE:OMC)
Pitcairn Co. boosted its holdings in Omnicom Group Inc. (NYSE:OMC – Free Report) by 20.4% in the 3rd quarter, HoldingsChannel.com...
Pitcairn Co. Has $642,000 Position in The Charles Schwab Co. (NYSE:SCHW)
Pitcairn Co. decreased its holdings in shares of The Charles Schwab Co. (NYSE:SCHW – Free Report) by 18.9% in the...
Algert Global LLC Raises Stake in Methode Electronics, Inc. (NYSE:MEI)
Algert Global LLC increased its position in shares of Methode Electronics, Inc. (NYSE:MEI – Free Report) by 228.2% during the...
Pitcairn Co. Decreases Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Pitcairn Co. decreased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.6% in the third quarter, according...